The IPO SPAC-Tacle

Episode Summary

Executive Summary: The episode examines the surge in IPOs and SPACs during 2020-2021, asking whether public markets are in a bubble or simply reflecting stronger fundamentals, low rates, and recovery optimism. Guest experts argue traditional IPO demand is supported by better companies and market conditions, while SPACs create more controversy due to structural dilution, even though their early-stage returns can look attractive.

Main Topics: 2020-2021 IPO market rebound (Priority: 5/5): The IPO market went from shutting down early in the pandemic to producing a strong second-half rebound, with U.S. issuance hitting record levels despite economic stress. Longer private-company lifecycles vs. renewed public-market appeal (Priority: 5/5): The discussion contrasts the post-2000 era of companies staying private longer with recent renewed enthusiasm for public listings as valuations improved and private funding remained abundant. Are IPO valuations a bubble? (Priority: 4/5): The speakers weigh comparisons to the late-1990s tech bubble, noting high multiples but also stronger fundamentals, lower rates, and successful public-market precedents. Why SPACs surged (Priority: 5/5): SPACs became a major share of listings because they offer speed, negotiated pricing, more capital access, and reduced execution risk, though with trade-offs. SPAC structure and investor returns (Priority: 5/5): Stanford’s Michael Klausner argues SPACs embed substantial dilution and tend to transfer value from post-merger shareholders, while Jay Ritter distinguishes strong pre-merger returns from weaker post-merger outcomes. What could slow or end the boom (Priority: 4/5): The guests identify higher rates, weaker vaccination/reopening confidence, declining deal quality, or a stock market selloff as possible triggers for a slowdown.

Key Arguments: The recent IPO boom is notable not just for size but for the mix of companies, including a record number of biotech listings and prominent tech names, suggesting some underlying business quality rather than pure speculation. Market conditions improved because investors are looking beyond the pandemic to 2022 and later, aided by vaccine optimism, low interest rates, and fiscal stimulus. High IPO valuations can be rationalized partly by lower risk-free rates and by the market's willingness to reward companies that can scale quickly and profitably. The current IPO environment differs from the late 1990s because many companies going public today are larger and more established than the young, less-developed firms that came to market then. SPACs are attractive to issuers because they can provide earlier market access, more capital, and a negotiated price, but they also introduce dilution from sponsor promote, warrants, underwriting costs, and redemptions. Klausner argues that SPAC returns are distorted by structure: pre-merger investors can earn attractive, low-risk returns while post-merger shareholders bear the dilution and often perform poorly. Both the IPO and SPAC markets remain highly sensitive to equity market sentiment; a broad stock-market downturn could quickly shut issuance windows. The future likely includes continued innovation across listing routes, with traditional IPOs remaining dominant but direct listings and SPACs taking larger shares over time. Data Points: Global IPO issuance in 2020: More than $300 billion - Total worldwide issuance during the 2020 IPO boom U.S. IPO issuance in 2020: $170 billion - Record U.S. issuance during the same period U.S. publicly traded companies in 2019: One of the lowest levels in two decades - Illustrates the prior contraction in public-company count U.S. operating-company IPOs in 2020: 165 - Jay Ritter’s count, excluding ADRs and SPACs U.S. operating-company IPOs in the 1990s: More than 300 per year - A typical year in the 1990s before the internet bubble burst U.S. SPAC IPOs in 2020: 248 - A major record and more than half of U.S. IPOs in the year U.S. SPACs in first three weeks of 2021: Around 60 - Shows the boom continued into early 2021 Biotech IPOs in 2020: 77 - The industry with the highest number of IPOs in the year Median tech IPO price-to-sales ratio pre-boom: About 6 - Typical tech IPO valuation in the last 20 years Median tech IPO price-to-sales ratio in 2018-2019: 10 to 11 - Rising valuations before the 2020 surge Median tech IPO price-to-sales ratio in 2020: About 24 - Approx. double the 2018-2019 level, highlighting rich valuations 30-year TIPS yield during internet bubble: About 400 basis points plus inflation - Used to contrast higher discount rates in the late 1990s 30-year TIPS yield today: About minus 30 basis points - Used to explain why higher equity multiples may be justified Average SPAC IPO investor return: 9.3% per year - Historical return between SPAC IPO and merger/liquidation Typical SPAC IPO size: About $200 million - Ritter’s description of a common SPAC IPO SPAC unit structure: $10 per unit, typically with a warrant to buy half a share or similar fraction at $11.50 - Illustrates standard SPAC investor terms SPAC trading premium in 2020: 1.6% average jump above $10 - SPACs began trading above their offer price more often in 2020 SPAC trading premium before 2020: 0.6% average jump above $10 - Historical comparison for initial SPAC trading performance SPAC IPOs in first week of January 2021: About 28 deals - Described as more than any previous week ever Average initial jump in first week of Jan. 2021 SPACs: More than 5% - Reflects strong investor demand at launch SPAC dilution hole at median: $6.60 of cash per $10 share - Klausner’s estimate of cash backing after structure-related dilution SPAC redemption range: 0% to 98% - Shows wide variability in how much cash remains after redemptions

Pivotal Quotes: "The answer depends on how we define IPOs." — Jay Ritter: Ritter explains why the 2020 IPO boom looks different depending on whether SPACs are included "These are businesses are actually backed by solid fundamentals." — David Ludwig: Ludwig argues current IPOs are stronger than those in the late 1990s "I think we may well be in a bubble." — Michael Klausner: Klausner’s conclusion about the SPAC market based on dilution and post-merger performance

Implications: Traditional IPOs may stay strong if rates remain low and recovery continues, but SPACs face mounting scrutiny over dilution and sustainability. Investors should distinguish between pre- and post-merger economics, and issuers may increasingly choose the route that best matches their financing and control needs.